Stroke, Vol 22, 1265-1269, Copyright © 1991 by American Heart Association
S Nag
BACKGROUND AND PURPOSE: Increased cerebrovascular permeability to protein
is a well-documented finding in acute and chronic hypertension. In this
study, we examined the effect of pretreatment with a calcium entry blocker,
flunarizine, on the increased cerebrovascular permeability to protein that
develops in norepinephrine-induced acute hypertension. METHODS: Protein
transfer was assessed qualitatively with Evans blue dye and quantitatively
with iodine-125-labeled serum albumin. RESULTS: Brains of hypertensive rats
showed increased permeability to both tracers. The number and size of the
areas of Evans blue extravasation were smaller in the hypertensive groups
pretreated with flunarizine intravenously. This was supported by the
quantitative studies, which demonstrated a significant decrease in protein
transfer in total brain of hypertensive rats pretreated with intravenous
flunarizine, 1 mg/kg (p less than 0.005) and 2.5 mg/kg (p less than 0.001).
Data from individual brain regions showed that pretreatment with
flunarizine resulted in significant reduction of protein transfer in most
brain regions. CONCLUSIONS: These data support the hypothesis that calcium
plays a role in increased cerebral endothelial permeability in
hypertension.
ARTICLES
Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats
Department of Pathology Neuropathology, Queen's University, Kingston, Ontario, Canada.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |